Domiciliary experience of the Target Inhalation Mode (TIM) breathing maneuver in patients with cystic fibrosis

Journal of Aerosol Medicine and Pulmonary Drug Delivery

Volumn 23, Issue SUPPL. 1, 2010, Pages

  Denyer, John ^a   Black, Alex ^b   Nikander, Kurt ^c   Dyche, Tony ^a   Prince, Ivan ^a  

^a Respiratory Drug Delivery UK Ltd   (United Kingdom)

^b Profile Pharma Ltd   (United Kingdom)

^c PHILIPS HEALTHCARE   (United States)

Author keywords

Adaptive aerosol delivery; Ease of use; I neb AAD system; Mesh nebulizer; Patient satisfaction

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; BREATHING MECHANICS; CHILD; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEM; HOME CARE; HUMAN; I NEB ADAPTIVE AEROSOL DELIVERY SYSTEM; NEBULIZER; PATIENT COMPLIANCE; PATIENT SATISFACTION; QUESTIONNAIRE; SCHOOL CHILD; TARGET INHALATION MODE;

ADOLESCENT; ADULT; ALGORITHMS; CHILD; CYSTIC FIBROSIS; DRUG DELIVERY SYSTEMS; HUMANS; MEDICATION ADHERENCE; MIDDLE AGED; NEBULIZERS AND VAPORIZERS; PATIENT ACCEPTANCE OF HEALTH CARE; PATIENT SATISFACTION; PHARMACEUTICAL PREPARATIONS; QUESTIONNAIRES; RESPIRATORY MECHANICS; TIME FACTORS; YOUNG ADULT;

EID: 77950615516     PISSN: 19412711     EISSN: 19412703     Source Type: Journal    
DOI: 10.1089/jamp.2009.0777     Document Type: Article

References (21)

1. Fink J: Metered-dose inhalers, dry powder inhalers, and transitions. Respir Care. 2000;45;623-635.
2. Newman SP, Pavia D, Garland N, and Clarke SW: Effects of various inhalation modes on the deposition of radioactive pressurized aerosols. Eur J Respir Dis. 1982;63(Suppl): 57-65.
3. Newman SP, Pavia D, and Clarke SW: How should pressurized beta-adrenergic bronchodilators be inhaled? Eur J Respir Dis. 1981;62:3-21.
4. Bennett WD, and Smaldone GC: Human variation in the peripheral air-space deposition of inhaled particles. J Appl Physiol. 1987;62:1603-1610.
5. Smaldone GC: Advances in aerosols: adult respiratory disease. J Aerosol Med. 2006;19:36-46.
6. Newman SP, Woodman G, and Clarke SW: Deposition of carbenicillin aerosols in cystic fibrosis: effects of nebuliser system and breathing pattern. Thorax. 1988;43:318-322.
7. Johnson DC, and Robart P: Inhaler technique of outpatients in the home. Respir Care. 2000;45;10:1182-1187.
8. Cochrane GM, Horne R, and Chanez P: Compliance in asthma. Respir Med. 1999;93:763-769.
9. Conway SP, Dodd ME, Marsden RJ, Paul EA, and Weller PH: Comparison of compliance in cystic fibrosis patients using either Halolite Adaptive Aerosol Delivery (AAD) system or a conventional high output nebulizer system. J Cyst Fibros. 2002;1:S67.
10. Denyer J, and Dyche T: Patient compliance with inhaled treatment using a novel aerosol delivery system. Proceedings of Drug Delivery to the Lung IX. The Aerosol Society, London, UK; pp. 124-127, 1998.
11. Corden ZM, Bosley CM, Rees PJ, and Cochrane GM: Home nebulised therapy with COPD. Chest. 1997;112:1278-1282.
12. Nikander K, and Denyer J: Adaptive Aerosol Delivery (AAD) Technology. In: Rathbone MJ (ed). Modified Release Drug Delivery Technology, 2nd ed. Informa Healthcare USA, Inc., New York, NY; pp. 603-612, 2008.
13. Prince I, Seamark D, Pinnuck M, Hinch S, Denyer J, and Conway J: Evaluation of a guided breathing manoeuvre for nebulised inhaled therapy. In: Byron PR, Dalby RN, Peart J, Suman JD, and Farr SJ (eds). Respiratory Drug Delivery IX. Virginia Commonwealth University, Richmond, VA; pp. 315-318, 2004.
14. Denyer J, Prince I, Dixon E, Agent P, Pryor J, and Hodson M: Evaluation of the Target Inhalation Mode (TIM) breathing maneuver in simulated nebulizer therapy in patients with cystic fibrosis. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S29-S36.
15. Likert R: A technique for the measurement of attitudes. Arch Psychol. 1932;22:1-55.
16. Bhapkar VP: A note on the equivalence of two test criteria for hypothesis in categorical data. J Am Stat Assoc. 1966;61: 228-235.
17. McNemar Q: Note on the sampling error of the difference between correlated proportions or percentages. Psychometrika. 1947;12:153-157.
18. Nikander K, Prince I, Coughlin S, Warren S, and Taylor G: Mode of breathing-tidal or slow and deep-through the I-neb Adaptive Aerosol Delivery (AAD) System affects lung deposition of 99mTc-DTPA. J Aerosol Med Pulm Drug Deliv. 2010;23(Suppl 1):S37-S44.
19. Nickerson C, Nikander K: Use of I-neb Insight for training and follow up of patients with pulmonary arterial hypertension. Respir Care. 2007;52:1623.
20. Ivanovich M, Kreamer JW, Gritzalis D, and Moses J: Evaluation of an auditory feedback equipped metered dose inhaler. Am J Ther. 1996;3:818-820.
21. Nikander K, Arheden L, Denyer J, and Cobos N: Parents' adherence with nebulizer treatment of their children when using an Adaptive Aerosol Delivery (AAD) System. J Aerosol Med. 2003;16:273-281.